What is the share price of Johnson Pharmacare Ltd (JOHNPHARMA) today?
The share price of JOHNPHARMA as on 18th September 2026 is ₹0.46. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Johnson Pharmacare Ltd (JOHNPHARMA) share?
The past returns of Johnson Pharmacare Ltd (JOHNPHARMA) share are- Past 1 week: N/A%
- Past 1 month: N/A%
- Past 3 months: -9.80%
- Past 6 months: -8.00%
- Past 1 year: -41.03%
- Past 3 years: -19.30%
- Past 5 years: 27.78%
What are the peers or stocks similar to Johnson Pharmacare Ltd (JOHNPHARMA)?
The peers or stocks similar to Johnson Pharmacare Ltd (JOHNPHARMA) include:What is the market cap of Johnson Pharmacare Ltd (JOHNPHARMA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Johnson Pharmacare Ltd (JOHNPHARMA) is ₹25.30 Cr as of 18th September 2026.What is the 52 week high and low of Johnson Pharmacare Ltd (JOHNPHARMA) share?
The 52-week high of Johnson Pharmacare Ltd (JOHNPHARMA) is ₹0.79 and the 52-week low is ₹0.45.What is the PE and PB ratio of Johnson Pharmacare Ltd (JOHNPHARMA) stock?
The P/E (price-to-earnings) ratio of Johnson Pharmacare Ltd (JOHNPHARMA) is -0.45. The P/B (price-to-book) ratio is 0.45.Which sector does Johnson Pharmacare Ltd (JOHNPHARMA) belong to?
Johnson Pharmacare Ltd (JOHNPHARMA) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Johnson Pharmacare Ltd (JOHNPHARMA) shares?
You can directly buy Johnson Pharmacare Ltd (JOHNPHARMA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Johnson Pharmacare Ltd
JOHNPHARMA Share Price
BSE₹0.462.13% (-0.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
JOHNPHARMA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
JOHNPHARMA Performance & Key Metrics
JOHNPHARMA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -0.45 | 0.45 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.20 | 5.92 | 0.48% |
JOHNPHARMA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
JOHNPHARMA Company Profile
Johnson Pharmacare Ltd is currently not engaged in any business activities and has not generated any revenues.
SUNPHARMA
PE Ratio
38.40
38.40
1Y Return
11.45%
11.45%
Buy Reco %
93.33
93.33
TORNTPHARM
PE Ratio
85.10
85.10
1Y Return
35.67%
35.67%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.96
22.96
1Y Return
10.70%
10.70%
Buy Reco %
55.56
55.56
CIPLA
PE Ratio
29.04
29.04
1Y Return
11.64%
11.64%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
118.79
118.79
1Y Return
111.64%
111.64%
Buy Reco %
58.33
58.33
JOHNPHARMA Forecast
JOHNPHARMA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
JOHNPHARMA
JOHNPHARMA
Income
Balance Sheet
Cash Flow
Quarterly Normal View
JOHNPHARMA Income Statement
JOHNPHARMA Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -0.33 | 0.00 | 0.00 | 0.00 | 1.58 | 0.00 | ||||||||||
Operating & Other expenses | 0.00 | 0.04 | 0.00 | 0.03 | 0.18 | 0.05 | 0.00 | 0.02 | 56.97 | 0.04 | ||||||||||
EBITDA | 0.00 | -0.04 | 0.00 | -0.03 | -0.51 | -0.05 | 0.00 | -0.02 | -55.39 | -0.04 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | 0.00 | -0.04 | 0.00 | -0.03 | -0.51 | -0.05 | 0.00 | -0.02 | -55.39 | -0.04 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.22 | 1.06 | ||||||||||
| PBT | 0.00 | -0.04 | 0.00 | -0.03 | -0.51 | -0.05 | 0.00 | -0.06 | -55.61 | -1.10 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | 0.00 | -0.04 | 0.00 | -0.03 | -0.51 | -0.05 | 0.00 | -0.06 | -55.61 | -1.10 | ||||||||||
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -1.01 | -0.02 |
JOHNPHARMA Company Updates
JOHNPHARMA Stock Peers
JOHNPHARMA Past Performance & Peer Comparison
JOHNPHARMA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Johnson Pharmacare Ltd | -0.45 | 0.45 | — |
| Sun Pharmaceutical Industries Ltd | 38.40 | 5.26 | 0.87% |
| Torrent Pharmaceuticals Ltd | 85.10 | 10.47 | 0.70% |
| Zydus Lifesciences Ltd | 22.96 | 3.91 | 0.09% |
JOHNPHARMA Stock Price Comparison
Compare JOHNPHARMA with any stock or ETFCompare JOHNPHARMA with any stock or ETF
JOHNPHARMA
JOHNPHARMA Holdings
JOHNPHARMA Shareholdings
JOHNPHARMA Promoter Holdings Trend
JOHNPHARMA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
JOHNPHARMA Institutional Holdings Trend
JOHNPHARMA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
JOHNPHARMA Shareholding Pattern
JOHNPHARMA Shareholding Pattern
JOHNPHARMA Shareholding History
JOHNPHARMA Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing JOHNPHARMA stock
smallcases containing JOHNPHARMA stock
Looks like this stock is not in any smallcase yet.
JOHNPHARMA Events
JOHNPHARMA Events
JOHNPHARMA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
JOHNPHARMA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
JOHNPHARMA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
JOHNPHARMA has not given any dividends in last 5 years
JOHNPHARMA Dividends
JOHNPHARMA Dividends
Hmm, looks like data is unavailable here. Please come back after some timeJOHNPHARMA Stock News & Opinions
JOHNPHARMA Stock News & Opinions
Articles & Videos
Corporate
Corporate
Johnson Pharmacare Ltd. confirms non-applicability for SEBI disclosure regulations for Q2 2026Johnson Pharmacare Ltd. informed the BSE Limited that the company is not applicable for compliance with Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended June 30th, 2026, as it has not issued shares via public issue, right issue, or preferential issue.
1 month agoCapital Market - Live
Corporate
Corporate
Johnson Pharmacare Ltd. moves registered office to a new location in AhmedabadJohnson Pharmacare Ltd. informed the BSE Limited that its board of directors approved shifting the company’s registered office from Desk No. 491-A, Office No. 4-D, Fourth Floor, Vardan Tower, Lakhudi Circle, East Wing, 2nd Floor, Near Sardar Patel Stadium, Navrangpura, Ahmedabad, Gujarat, 380009 to Shop No. I-460, Fourth Floor, Titanium City Centre Mall, Near Sachin Tower, Anand Nagar Road, Satellite, Ahmedabad – 380015, as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
1 month agoCapital Market - Live
Corporate
Corporate
Johnson Pharmacare Ltd. to approve quarterly results at a board meeting on August 13Johnson Pharmacare Ltd. will hold a board meeting on Thursday, August 13, to approve the unaudited standalone financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. The company closed its trading window on July 1, 2026, and it will remain closed until 48 hours after the unaudited results are declared.
1 month agoCapital Market - Live
Earnings
Earnings
Johnson Pharmacare reports standalone net loss of Rs 55.61 crore in the March 2026 quarterNet Loss of Johnson Pharmacare reported to Rs 55.61 crore in the quarter ended March 2026 as against net loss of Rs 0.51 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025. For the full year,net loss reported to Rs 55.73 crore in the year ended March 2026 as against net loss of Rs 0.58 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Johnson Pharmacare schedules board meetingJohnson Pharmacare will hold a meeting of the Board of Directors of the Company on 27 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Johnson Pharmacare reports standalone net loss of Rs 0.06 crore in the December 2025 quarterNet Loss of Johnson Pharmacare reported to Rs 0.06 crore in the quarter ended December 2025 as against net loss of Rs 0.03 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Johnson Pharmacare postpones board meetingJohnson Pharmacare has postponed the meeting of the Board of Directors which was scheduled to be held on 12 February 2026. The meeting will now be held on 14 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Johnson Pharmacare schedules board meetingJohnson Pharmacare will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Johnson Pharmacare reports standalone nil net profit/loss in the September 2025 quarterJohnson Pharmacare reported no net profit/loss in the quarter ended September 2025 and during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Johnson Pharmacare announces board meeting dateJohnson Pharmacare will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 15.76%, vs industry avg of 11.76%
Over the last 5 years, market share stayed at 0%